Reliq Health Technologies Inc V.RHT.H

20mln shares free trading Mar 3/2018, most of it $.40 paper

[blackgold909]

Reliq Health Technologies Announces Closing of Oversubscribed $5 Million Brokered Private Placement
2017-11-02 12:52:49.593 GMT

Reliq Health Technologies Announces Closing of Oversubscribed $5 Million
Brokered Private Placement

Not for dissemination in the United States or through U.S. newswire services

VANCOUVER, B.C., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Reliq Health Technologies 
Inc. (TSXV:RHT) (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company
focused on developing innovative mobile health (mHealth) and telemedicine 
solutions for Community-Based Healthcare, is pleased to announce further to 
its news releases dated October 11 and 30, 2017, it successfully closed an 
oversubscribed private placement (the “Offering”) led by Canaccord Genuity 
Corp and Gravitas Securities Inc. (together, the “Co-Lead Agents”) and Beacon 
Securities Limited (“Beacon” and together with the Co-Lead Agents, the 
“Agents”) of 12,500,000 Units (the “Units”) of the Company at a price of $0.40
per Unit (the “Unit Price”) for gross proceeds of $5,000,000.

Each Unit consists of one (1) common share of the Company (a “Common Share”) 
and half of one (1/2) Common Share purchase warrant (each whole Common Share 
purchase warrant, a “Warrant”). Each of the 6,250,000 Warrants is exercisable 
to acquire one Common Share (a “Warrant Share”) for a period of two years 
following the closing date of the Offering at an exercise price of $0.60 per 
Warrant Share, subject to adjustment in certain events.

“We are very pleased to have completed a successful oversubscribed financing 
and to have two of Canada’s leading independent brokerage firms support the 
Company,” said Dr. Lisa Crossley, CEO of Reliq.

The Company intends to use the net proceeds of the Offering for general 
working capital, product development and customer acquisition.

In connection with the Offering, the Company paid the Agents a cash fee of 
$340,000 and issued 625,000 Units to the Agents. Additionally, the Company 
issued 850,000 compensation warrants to the Agents and other selling dealer 
group members (the “Compensation Warrants”), with each Compensation Warrant 
entitling the holder to purchase one Unit of the Company at an exercise price 
of $0.40 for a period of two years following the closing date of the Offering.
Each warrant issued under the Units is exercisable into one Common Share of 
the Company for a period of two years following the exercise of the 
Compensation Warrant at an exercise price of $0.60 per Common Share, subject 
to adjustment in certain events.

All securities issued in connection with the Offering are subject to a four 
month hold period expiring March 3, 2018. 

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director